Neurobiological Mechanisms Of Depression Following Traumatic Brain Injury

References

• Centers for disease control and prevention, national center for health statistics: mortality data on CDC WONDER. 2019. [accessed 2022 Feb 1]. https://wonder.cdc.gov/mcd.html
   Google Scholar
• Jourdan C, Azouvi P, Genêt F, Selly N, Josseran L, Schnitzler A. Disability and health consequences of traumatic brain injury national prevalence. Am J Phys Med Rehabil. 2018;97(5):323–31. doi:10.1097/PHM.0000000000000848. Cited in: PMID: 29016402.
   PubMed Web of Science ®Google Scholar
• Kreutzer JS, Seel RT, Gourley E. The prevalence and symptom rates of depression after traumatic brain injury: a comprehensive examination. Brain Inj. 2001;15(7):563–76. doi:10.1080/02699050010009108. Cited in: PMID: 11429086.
   PubMed Web of Science ®Google Scholar
• Seel RT, Kreutzer JS, Rosenthal M, Hammond FM, Corrigan JD, Black K. Depression after traumatic brain injury: a National institute on disability and rehabilitation research model systems multicenter investigation. Arch Phys Med Rehabil. 2003;84(2):177–84. doi:10.1053/apmr.2003.50106. Cited in: PMID: 12601647.
   PubMed Web of Science ®Google Scholar
• Malec JF, Brown AW, Moessner AM, Stump TE, Monahan P. A preliminary model for posttraumatic brain injury depression. Arch Phys Med Rehabil. 2010;91(7):1087–97. doi:10.1016/j.apmr.2010.04.002. Cited in: PMID: 20599048.
   PubMed Web of Science ®Google Scholar
• Kumar RG, Gao S, Juengst SB, Wagner AK, Fabio A. The effects of post-traumatic depression on cognition, pain, fatigue, and headache after moderate-to-severe traumatic brain injury: a thematic review. Brain Inj. 2018;32(4):383–94. doi:10.1080/02699052.2018.1427888. Cited in: PMID: 29355429.
   PubMed Web of Science ®Google Scholar
• Jorge RE, Starkstein SE. Pathophysiologic aspects of major depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20(6):475–87. doi:10.1097/00001199-200511000-00001. Cited in: PMID:16304485.
   PubMed Web of Science ®Google Scholar
• Miles SR, Hammond FM, Neumann D, Silva MA, Tang X, Kajankova M, Dillahunt-Aspillaga C, Nakase-Richardson R. Evolution of irritability, anger, and aggression after traumatic brain injury: identifying and predicting subgroups. J Neurotrauma. 2021;38(13):1827–33. doi:10.1089/neu.2020.7451. Cited in: PMID: 33470179.
   PubMed Web of Science ®Google Scholar
• Howlett JR, Nelson LD, Stein MB. Mental health consequences of traumatic brain injury. Biol Psych. 2022;91(5):413–20. doi:10.1016/j.biopsych.2021.09.024. Cited in: PMID: 34893317.
   PubMed Web of Science ®Google Scholar
• Harnod D, Harnod T, Lin CL, Shen WC, Kao CH. Increased risks of suicide attempt and suicidal drug overdose following admission for head injury in patients with depression. Int J Environ Res Public Health. 2019;16(19):3524. doi:10.3390/ijerph16193524. Cited in: PMID: 3154720.
   PubMed Web of Science ®Google Scholar
• Kivunja S, River J, Gullick J. Experiences of giving and receiving care in traumatic brain injury: an integrative review. J Clin Nurs. 2018;27(7–8):1304–28. doi:10.1111/jocn.14283. Cited in: PMID: 29396883.
   PubMed Web of Science ®Google Scholar
• Narapareddy BR, Narapareddy L, Lin A, Wigh S, Nanavati J, Dougherty J 3rd, Nowrangi M, Roy D. Treatment of depression after traumatic brain injury: a systematic review focused on pharmacological and neuromodulatory interventions. Psychosomatics. 2020 Sep-Oct;61(5):481–97. doi:10.1016/j.psym.2020.04.012. 2020. Cited in: PMID: 32660873.
   PubMed Web of Science ®Google Scholar
• Roy D, Koliatsos V, Vaishnavi S, Han D, Rao V. Risk factors for new-onset depression after first-time traumatic brain injury. Psychosomatics. 2018;59(1):47–57. doi:10.1016/j.psym.2017.07.008. Cited in: PMID: 28844451.
   PubMed Web of Science ®Google Scholar
• Wang Y, Neumann M, Hansen K, Hong SM, Kim S, Noble-Haeusslein LJ, Liu J. Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. J Neurotrauma. 2011 Feb;28(2):259–68. doi:10.1089/neu.2010.1648. Cited in: PMID: 21175261.
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Depalma L, Devivo MJ, Guin-Renfroe S, Novack TA. Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Inj. 2001 Apr;15(4):321–31. doi:10.1080/026990501750111274. Cited in: PMID: 11299133.
   PubMed Web of Science ®Google Scholar
• Rapoport MJ, Chan F, Lanctot K, Herrmann N, McCullagh S, Feinstein A. An open-label study of citalopram for major depression following traumatic brain injury. J Psychopharmacol. 2008 Nov;22(8):860–64. doi:10.1177/0269881107083845. Epub 2008 Jan 21. Cited in: PMID: 18208921.
   PubMed Web of Science ®Google Scholar
• Fann JR, Bombardier CH, Vannoy S, Dyer J, Ludman E, Dikmen S, Marshall K, Barber J, Temkin N. Telephone and in-person cognitive behavioral therapy for major depression after traumatic brain injury: a randomized controlled trial. J Neurotrauma. 2015 Jan 1;32(1):45–57. doi:10.1089/neu.2014.3423. Cited in: PMID: 25072405; PMCID: PMC4273196.
   PubMed Web of Science ®Google Scholar
• Khan-Bourne N, Brown RG. Cognitive behaviour therapy for the treatment of depression in individuals with brain injury. NeuropsycholRehabil. 2003 Jan-Mar;13(1–2):89–107. doi:10.1080/09602010244000318. Cited in: PMID: 21854329.
   Web of Science ®Google Scholar
• Kreitzer N, Ancona R, McCullumsmith C, Kurowski BG, Foreman B, Ngwenya LB, Adeoye O. The effect of antidepressants on depression after traumatic brain injury: a meta-analysis. J Head Trauma Rehabil. 2019 May;34(3):E47–E54. doi:10.1097/HTR.0000000000000439. Cited in: PMID: 30169440.
   PubMed Web of Science ®Google Scholar
• Cheng YS, Tseng PT, Wu YC, Tu YK, Wu CK, Hsu CW, Lei WT, Li DJ, Chen TY, Stubbs B, et al. Therapeutic benefits of pharmacologic and nonpharmacologic treatments for depressive symptoms after traumatic brain injury: a systematic review and network meta-analysis. J Psychiatry Neurosci. 2021 Jan 21;46(1):E196–E207. doi:10.1503/jpn.190122. Cited in: PMID: 33497170.
   PubMed Web of Science ®Google Scholar
• Köhler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, Krogh J. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014 1;71(12):1381–91. doi:10.1001/jamapsychiatry.2014.1611. Cited in: PMID: 25322082.
   PubMed Web of Science ®Google Scholar
• Fenn AM, Skendelas JP, Moussa DN, Muccigrosso MM, Popovich PG, Lifshitz J, Eiferman DS, Godbout JP. Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice. J Neurotrauma. 2015 Jan 15;32(2):127–38. doi:10.1089/neu.2014.3514. 2014. Cited in: PMID: 25070744; PMCID: PMC4291210.
   PubMed Web of Science ®Google Scholar
• Lim SW, Sung KC, Shiue YL, Wang CC, Chio CC, Kuo JR. Hyperbaric oxygen effects on depression-like behavior and neuroinflammation in traumatic brain injury rats. World Neurosurg. 2017;100:128–37. doi:10.1016/j.wneu.2016.12.118. Cited in: PMID: 28065873.
   PubMed Web of Science ®Google Scholar
• Lim J, Kim HI, Bang Y, Choi HJ. Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis. Arch Pharm Res. 2021 Jun;44(6):553–63. doi:10.1007/s12272-021-01333-7. 2021. Cited in: PMID: 34138417.
   PubMed Web of Science ®Google Scholar
• Lim SW, Shiue YL, Liao JC, Wee HY, Wang CC, Chio CC, Chang CH, Hu CY, Kuo JR. Simvastatin therapy in the acute stage of traumatic brain injury attenuates brain trauma-induced depression-like behavior in rats by reducing neuroinflammation in the hippocampus. Neurocrit Care. 2017;26(1):122–32. doi:10.1007/s12028-016-0290-6. Cited in: PMID: 27406816.
   PubMed Web of Science ®Google Scholar
• Ghajar J. Traumatic brain injury. Lancet. 2000;356(9233):923–29. doi:10.1016/S0140-6736(00)02689-1. Cited in: PMID: 11036909.
   PubMed Web of Science ®Google Scholar
• Ladak AA, Enam SA, Ibrahim MT. A review of the molecular mechanisms of traumatic brain injury. World Neurosurg. 2019;131:126–32. doi:10.1016/j.wneu.2019.07.039. Cited in: PMID: 31301445.
   PubMed Web of Science ®Google Scholar
• Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13:528. doi:10.3389/fncel.2019.00528. Cited in: PMID: 31827423.
   PubMed Web of Science ®Google Scholar
• Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron. 2017;95(6):1246–65. doi:10.1016/j.neuron.2017.07.010. Cited in: PMID: 28910616.
   PubMed Web of Science ®Google Scholar
• Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics. 2010;7(1):22–30. doi:10.1016/j.nurt.2009.10.016. Cited in: PMID: 20129494.
   PubMed Web of Science ®Google Scholar
• Needham EJ, Helmy A, Zanier ER, Jones JL, Coles AJ, Menon DK. The immunological response to traumatic brain injury. J Neuroimmunol. 2019;332:112–25. doi:10.1016/j.jneuroim.2019.04.005. Cited in: PMID: 31005712.
   PubMed Web of Science ®Google Scholar
• Simon DW, McGeachy MJ, Bayır H, Clark RS, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(3):171–91. doi:10.1038/nrneurol.2017.13. Cited in: PMID: 28186177.
   PubMed Web of Science ®Google Scholar
• Henze K, Martin W. Evolutionary biology: essence of mitochondria. Nature. 2003;426(6963):127–28. doi:10.1038/426127a. Cited in: PMID: 14614484.
   PubMed Web of Science ®Google Scholar
• Hinzman JM, Wilson JA, Mazzeo AT, Bullock MR, Hartings JA. Excitotoxicity and metabolic crisis are associated with spreading depolarizations in severe traumatic brain injury patients. J Neurotrauma. 2016;33(19):1775–83. doi:10.1089/neu.2015.4226. Cited in: PMID: 26586606.
   PubMed Web of Science ®Google Scholar
• Veech RL, Valeri CR, VanItallie TB. The mitochondrial permeability transition pore provides a key to the diagnosis and treatment of traumatic brain injury. IUBMB Life. 2012;64(2):203–07. doi:10.1002/iub.590. Cited in: PMID: 22241645.
   PubMed Web of Science ®Google Scholar
• Khatri N, Thakur M, Pareek V, Kumar S, Sharma S, Datusalia AK. Oxidative stress: major threat in traumatic brain injury. CNS Neurol Disord Drug Targets. 2018;17(9):689–95. doi:10.2174/1871527317666180627120501. Cited in: PMID: 29952272.
   PubMed Web of Science ®Google Scholar
• Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909–50. doi:10.1152/physrev.00026.2013. Cited in: PMID: 24987008.
   PubMed Web of Science ®Google Scholar
• Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res. 2009;43(4):348–64. doi:10.1080/10715760902751902. Cited in: PMID: 19241241.
   PubMed Web of Science ®Google Scholar
• Kozlov AV, Bahrami S, Redl H, Szabo C. Alterations in nitric oxide homeostasis during traumatic brain injury. BiochimBiophys Acta Mol Basis Dis. 2017;1863(10 Pt B):2627–32. doi:10.1016/j.bbadis.2016.12.020. Cited in: PMID: 28064018.
   PubMed Web of Science ®Google Scholar
• Czarny P, Wigner P, Galecki P, Sliwinski T. The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80(Pt C):309–21. doi:10.1016/j.pnpbp.2017.06.036. Cited in: PMID: 28669580.
   PubMed Web of Science ®Google Scholar
• Hahn WS, Kuzmicic J, Burrill JS, Donoghue MA, Foncea R, Jensen MD, Lavandero S, Arriaga EA, Bernlohr DA. Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics. Am J Physiol Endocrinol Metab. 2014;306(9):1033–45. doi:10.1152/ajpendo.00422.2013. Cited in: PMID: 24595304.
   Web of Science ®Google Scholar
• McGuire JL, Ngwenya LB, McCullumsmith RE. Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies. Mol Psychiatry. 2019;24(7):995–1012. doi:10.1038/s41380-018-0239-6. Cited in: PMID: 30214042.
   PubMed Web of Science ®Google Scholar
• Guerriero RM, Giza CC, Rotenberg A. Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep. 2015;15(5):27. doi:10.1007/s11910-015-0545-1. Cited in: PMID: 25796572.
   PubMed Web of Science ®Google Scholar
• Eierud C, Craddock RC, Fletcher S, Aulakh M, King-Casas B, Kuehl D, LaConte SM. Neuroimaging after mild traumatic brain injury: review and meta-analysis. Neuroimage Clin. 2014 Jan 4;4:283–94. doi:10.1016/j.nicl.2013.12.009. Cited in: PMID: 25061565.
   PubMed Web of Science ®Google Scholar
• Le TH, Gean AD. Neuroimaging of traumatic brain injury. Mt Sinai J Med. 2009 Apr;76(2):145–62. doi:10.1002/msj.20102. Cited in: PMID: 19306377.
   PubMedGoogle Scholar
• Smith LGF, Milliron E, Ho ML, Hu HH, Rusin J, Leonard J, Sribnick EA. Advanced neuroimaging in traumatic brain injury: an overview. Neurosurg Focus. 2019 Dec;47(6):E17. doi:10.3171/2019.9.FOCUS19652. Erratum in: Neurosurg Focus. 2021 Jan;50(1):E22. Cited in: PMID: 32364704.
   PubMed Web of Science ®Google Scholar
• Irimia A, Van Horn JD. Functional neuroimaging of traumatic brain injury: advances and clinical utility. Neuropsychiatr Dis Treat. 2015 Sep 15;11:2355–65. doi:10.2147/NDT.S79174. Cited in: PMID: 26396520.
   PubMed Web of Science ®Google Scholar
• Belanger HG, Vanderploeg RD, Curtiss G, Warden DL. Recent neuroimaging techniques in mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2007;19(1):5–20. doi:10.1176/jnp.2007.19.1.5. Winter, Cited in: PMID: 17308222.
   PubMed Web of Science ®Google Scholar
• Lin AP, Liao HJ, Merugumala SK, Prabhu SP, Meehan WP 3rd, Ross BD. Metabolic imaging of mild traumatic brain injury. Brain Imaging Behav. 2012 Jun;6(2):208–23. doi:10.1007/s11682-012-9181-4. Cited in: PMID: 22684770.
   PubMed Web of Science ®Google Scholar
• Kato T, Nakayama N, Yasokawa Y, Okumura A, Shinoda J, Iwama T. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury. J Neurotrauma. 2007 Jun;24(6):919–26. doi:10.1089/neu.2006.0203. Cited in: PMID: 17600509.
   PubMed Web of Science ®Google Scholar
• Garnett MR, Corkill RG, Blamire AM, Rajagopalan B, Manners DN, Young JD, Styles P, Cadoux-Hudson TA. Altered cellular metabolism following traumatic brain injury: a magnetic resonance spectroscopy study. J Neurotrauma. 2001 Mar;18(3):231–40. doi:10.1089/08977150151070838. PMID: 11284544.
   PubMed Web of Science ®Google Scholar
• Shin SS, Bales JW, Edward Dixon C, Hwang M. Structural imaging of mild traumatic brain injury may not be enough: overview of functional and metabolic imaging of mild traumatic brain injury. Brain Imaging Behav. 2017 Apr;11(2):591–610. doi:10.1007/s11682-017-9684-0. PMID: 28194558.
   PubMed Web of Science ®Google Scholar
• Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nat Rev Dis Primers. 2016;2(1):16065. doi:10.1038/nrdp.2016.65. Cited in: PMID: 27629598.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002 Mar 28;34(1):13–25. doi:10.1016/s0896-6273(02)00653-0. Cited in: PMID: 11931738.
   PubMed Web of Science ®Google Scholar
• Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014 Dec;169:15–20. Epub 2014 Jul 30. Cited in: PMID: 25128861. doi:10.1016/j.jad.2014.07.032
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol. 2004 Aug;19(6):397–403. doi:10.1002/hup.609. Cited in: PMID: 15303243.
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006 Jan;27(1):24–31. doi:10.1016/j.it.2005.11.006. Epub 2005 Nov 28. Cited in: PMID: 16316783.
   PubMed Web of Science ®Google Scholar
• Pariante CM. Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol. 2017;27(6):554–59. doi:10.1016/j.euroneuro.2017.04.001. Cited in: PMID: 28479211.
   PubMed Web of Science ®Google Scholar
• Iob E, Kirschbaum C, Steptoe A. Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms. Mol Psychiatry. 2020;25(5):1130–40. doi:10.1038/s41380-019-0501-6. Cited in: PMID: 31435001.
   PubMed Web of Science ®Google Scholar
• Leistner C, Menke A. Hypothalamic-pituitary-adrenal axis and stress. Handb Clin Neurol. 2020;175:55–64. doi:10.1016/B978-0-444-64123-6.00004-7. Cited in: PMID: 33008543.
   PubMedGoogle Scholar
• Ménard C, Pfau ML, Hodes GE, Russo SJ. Immune and neuroendocrine mechanisms of stress vulnerability and resilience. Neuropsychopharmacology. 2017 Jan;42(1):62–80. doi:10.1038/npp.2016.90. Cited in: PMID: 27291462.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. Glucocorticoids, the evolution of the stress-response, and the primate predicament. neurobiology of Stress. 2021;14:100320. doi:10.1016/j.ynstr.2021.100320. Cited in: PMID: 33869683.
   PubMed Web of Science ®Google Scholar
• Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403–16. doi:10.1080/10253890.2018.1470238. Cited in: PMID: 29764284.
   PubMed Web of Science ®Google Scholar
• Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):722–29. doi:10.1016/j.pnpbp.2010.04.011. Cited in: PMID: 20406665.
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Beekman AT, van Reedtdortland AK, Schoevers RA, Giltay EJ, de Jonge P, Penninx BW. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology. 2014 Jun;39(7):1624–34. doi:10.1038/npp.2014.9. Cited in: PMID: 24442097.
   PubMed Web of Science ®Google Scholar
• Choi GE, Han HJ. Glucocorticoid impairs mitochondrial quality control in neurons. Neurobiol Dis. 2021;152:105301. doi:10.1016/j.nbd.2021.105301. Cited in: PMID: 33609641.
   PubMed Web of Science ®Google Scholar
• Hunter RG, Seligsohn M, Rubin TG, Griffiths BB, Ozdemir Y, Pfaff DW, Datson NA, McEwen BS. Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Proc Natl Acad Sci U S A. 2016;113(32):9099–104. doi:10.1073/pnas.1602185113. Cited in: PMID: 27457949.
   PubMed Web of Science ®Google Scholar
• Belleau EL, Treadway MT, Pizzagalli DA. The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology. Biol Psychiatry. 2019;85(6):443–53. doi:10.1016/j.biopsych.2018.09.031. Cited in: PMID: 30470559.
   PubMed Web of Science ®Google Scholar
• Liu CH, Zhang GZ, Li B, Li M, Woelfer M, Walter M, Wang L. Role of inflammation in depression relapse. J Neuroinflammation. 2019;16(1):90. doi:10.1186/s12974-019-1475-7. Cited in: PMID: 30995920.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 2016;17(8):497–511. doi:10.1038/nrn.2016.69. Cited in: PMID: 27277867.
   PubMed Web of Science ®Google Scholar
• Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23(1):48–58. doi:10.1038/mp.2017.205. Cited in: PMID: 29133955.
   PubMed Web of Science ®Google Scholar
• Ghasemi M. Nitric oxide: antidepressant mechanisms and inflammation. Adv Pharmacol. 2019;86:121–52. doi:10.1016/bs.apha.2019.04.004. Cited in: PMID: 31378250.
   PubMedGoogle Scholar
• McLeod TM, López-Figueroa AL, López-Figueroa MO. Nitric oxide, stress, and depression. Psychopharmacol Bull. 2001;35(1):24–41. Cited in: PMID: 12397868 Winter.
   PubMedGoogle Scholar
• Bodnar CN, Morganti JM, Bachstetter AD. Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism. Neural Regen Res. 2018;13(10):1693–704. doi:10.4103/1673-5374.238604. Cited in: PMID: 30136679.
   PubMed Web of Science ®Google Scholar
• Caruso G, Benatti C, Blom JMC, Caraci F, Tascedda F. The many faces of mitochondrial dysfunction in depression: from pathology to treatment. Front Pharmacol. 2019;10:995. doi:10.3389/fphar.2019.00995. Cited in: PMID: 31551791.
   PubMed Web of Science ®Google Scholar
• Tamási V, Petschner P, Adori C, Kirilly E, Ando RD, Tothfalusi L, Juhasz G, Bagdy G. Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes. PLoS One. 2014;9(11):e113662. doi:10.1371/journal.pone.0113662. Cited in: PMID: 25423262.
   PubMed Web of Science ®Google Scholar
• Eren I, Naziroğlu M, Demirdaş A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res. 2007;32(7):1188–95. doi:10.1007/s11064-007-9289-x. Cited in: PMID: 17401662.
   PubMed Web of Science ®Google Scholar
• Gong Y, Chai Y, Ding JH, Sun XL, Hu G. Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain. Neurosci Lett. 2011;488(1):76–80. doi:10.1016/j.neulet.2010.11.006. Cited in: PMID:21070835.
   PubMed Web of Science ®Google Scholar
• Gamaro GD, Streck EL, Matté C, Prediger ME, Wyse AT, Dalmaz C. Reduction of hippocampal Na+, K+-ATPase activity in rats subjected to an experimental model of depression. Neurochem Res. 2003;28(9):1339–44. doi:10.1023/a:1024988113978. Cited in: PMID: 12938855.
   PubMed Web of Science ®Google Scholar
• Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, Dong MX, Chen JJ, Ye F, Wang HY, Zheng P, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8(1):130. doi:10.1038/s41398-018-0183-x. Cited in: PMID: 29991685.
   PubMed Web of Science ®Google Scholar
• Maes M, Ringel K, Kubera M, Berk M, Rybakowski J. Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012;136(3):386–92. doi:10.1016/j.jad.2011.11.016. Cited in: PMID: 22166399.
   PubMed Web of Science ®Google Scholar
• Arango V, Underwood MD, Mann JJ. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res. 2002;136:443–53. doi:10.1016/s0079-6123(02)36037-0. Cited in: PMID: 12143401.
   PubMed Web of Science ®Google Scholar
• Joensuu M, Tolmunen T, Saarinen PI, Tiihonen J, Kuikka J, Ahola P, Vanninen R, Lehtonen J. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Res. 2007 Feb 28;154(2):125–31. doi:10.1016/j.pscychresns.2006.08.001. Epub 2007 Feb 7. Cited in: PMID: 17289353.
   PubMed Web of Science ®Google Scholar
• Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Dwork AJ, Mann JJ, Arango V. Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. Transl Psychiatry. 2018 Dec 14;8(1):279. doi:10.1038/s41398-018-0309-1. Cited in: PMID: 30552318.
   PubMed Web of Science ®Google Scholar
• Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010 May;167(5):509–27. doi:10.1176/appi.ajp.2010.09101452. Epub 2010 Mar 15. Cited in: PMID: 20231323.
   PubMed Web of Science ®Google Scholar
• Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102(1):75–90. doi:10.1016/j.neuron.2019.03.013. Cited in: PMID: 30946828.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Stockmeier CA. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets. 2013;14(11):1225–36. doi:10.2174/13894501113149990156. Cited in: PMID: 234699229810.
   PubMed Web of Science ®Google Scholar
• Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815. doi:10.1037/a0035302. Cited in: PMID: 24417575.
   PubMed Web of Science ®Google Scholar
• Haroon E, Chen X, Li Z, Patel T, Woolwine BJ, Hu XP, Felger JC, Miller AH. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia. Transl Psychiatry. 2018;8(1):189. doi:10.1038/s41398-018-0241-4. Cited in: PMID: 30202011.
   PubMed Web of Science ®Google Scholar
• Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70–82. doi:10.1016/j.neuropharm.2014.10.027. Cited in: PMID: 25445483.
   PubMed Web of Science ®Google Scholar
• van Velzen LS, Kelly S, Isaev D, Aleman A, Aftanas LI, Bauer J, Baune BT, Brak IV, Carballedo A, Connolly CG, et al. White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group. Mol Psychiatry. 2020 Jul;25(7):1511–25. DOI:10.1038/s41380-019-0477-2. Epub 2019 Aug 30. Cited in: PMID: 31471575.
   PubMed Web of Science ®Google Scholar
• Tham MW, Woon PS, Sum MY, Lee TS, Sim K. White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies. J Affect Disord. 2011 Jul;132(1–2):26–36. doi:10.1016/j.jad.2010.09.013. Epub 2010 Oct 2. Cited in: PMID: 20889213.
   PubMed Web of Science ®Google Scholar
• de Diego-Adeliño J, Pires P, Gómez-Ansón B, Serra-Blasco M, Vives-Gilabert Y, Puigdemont D, Martín-Blanco A, Alvarez E, Pérez V, Portella MJ. Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychol Med. 2014 Apr;44(6):1171–82. doi:10.1017/S003329171300158X. Epub 2013 Aug 21. Cited in: PMID: 23962469.
   PubMed Web of Science ®Google Scholar
• Cole J, Chaddock CA, Farmer AE, Aitchison KJ, Simmons A, McGuffin P, Fu CH. White matter abnormalities and illness severity in major depressive disorder. Br J Psychiatry. 2012 Jul;201(1):33–39. doi:10.1192/bjp.bp.111.100594. Epub 2012 May 10. Cited in: PMID: 22576724.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu X, Luo Q, Luo Y, Chen Y, Lui S, Wu M, Zhu H, Kemp GJ, Gong Q. Brain grey matter volume alterations associated with antidepressant response in major depressive disorder. Sci Rep. 2017 Sep 5;7(1):10464. doi:10.1038/s41598-017-10676-5. Cited in: PMID: 28874763.
   PubMed Web of Science ®Google Scholar
• Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, Bullmore E. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry. 2007 Sep 1;62(5):407–14. doi:10.1016/j.biopsych.2006.09.018. Epub 2007 Jan 9. Cited in: PMID: 17217921.
   PubMed Web of Science ®Google Scholar
• Anand A, Li Y, Wang Y, Wu J, Gao S, Bukhari L, Mathews VP, Kalnin A, Lowe MJ. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol Psychiatry. 2005 May 15;57(10):1079–88. doi:10.1016/j.biopsych.2005.02.021. Cited in: PMID: 15866546.
   PubMed Web of Science ®Google Scholar
• Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-Scale Network Dysfunction in Major Depressive Disorder: a Meta-analysis of Resting-State Functional Connectivity. JAMA Psychiatry. 2015 Jun;72(6):603–11. doi:10.1001/jamapsychiatry.2015.0071. Cited in: PMID: 25785575.
   PubMed Web of Science ®Google Scholar
• Chan KL, Cathomas F, Russo SJ. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology (Bethesda). 2019;34(2):123–33. doi:10.1152/physiol.00047.2018. Cited in: PMID: 30724127.
   PubMed Web of Science ®Google Scholar
• Sharma S, Akundi RS. Mitochondria: a connecting link in the major depressive disorder jigsaw. CurrNeuropharmacol. 2019;17(6):550–62. doi:10.2174/1570159X16666180302120322. Cited in: PMID: 29512466.
   Web of Science ®Google Scholar
• Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98(1):477–504. doi:10.1152/physrev.00039.2016. Cited in: PMID: 29351513.
   PubMed Web of Science ®Google Scholar
• Popovic V, Pekic S, Pavlovic D, Maric N, Jasovic-Gasic M, Djurovic B, Medic-Stojanoska M, Zivkovic V, Stojanovic M, Doknic M, et al. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest. 2004 Dec;27(11):1048–54. DOI:10.1007/BF03345308. Cited in: PMID: 15754737.
   PubMed Web of Science ®Google Scholar
• Bay E, Covassin T. Chronic stress, somatic and depressive symptoms following mild to moderate traumatic brain injury. Arch PsychiatrNurs. 2012 Dec;26(6):477–86. doi:10.1016/j.apnu.2012.06.002. Cited in: PMID: 23164404.
   PubMed Web of Science ®Google Scholar
• Bay E, Sikorskii A, Gao F. Functional status, chronic stress, and cortisol response after mild-to-moderate traumatic brain injury. Biol Res Nurs. 2009 Jan;10(3):213–25. doi:10.1177/1099800408326453. Epub 2008 Nov 17. Cited in: PMID: 19015162.
   PubMed Web of Science ®Google Scholar
• Bay E, Hagerty B, Williams RA, Kirsch N. Chronic stress, salivary cortisol response, interpersonal relatedness, and depression among community-dwelling survivors of traumatic brain injury. J NeurosciNurs. 2005 Feb;37(1):4–14. doi:10.1097/01376517-200502000-00002. PMID: 15794439.
   Google Scholar
• Luo L, Chai Y, Jiang R, Chen X, Yan T. Cortisol supplement combined with psychotherapy and citalopram improves depression outcomes in patients with hypocortisolism after traumatic brain injury. Aging Dis. 2015 Nov 17;6(6):418–25. doi:10.14336/AD.2015.0507. Cited in: PMID: 26618043.
   PubMed Web of Science ®Google Scholar
• Moreno-López L, Sahakian BJ, Manktelow A, Menon DK, Stamatakis EA. Depression following traumatic brain injury: a functional connectivity perspective. Brain Inj. 2016;30(11):1319–28. doi:10.1080/02699052.2016.1186839. Epub 2016 Jul 28. Cited in: PMID: 2746789.
   PubMed Web of Science ®Google Scholar
• Bergold PJ. Treatment of traumatic brain injury with anti-inflammatory drugs. Experimental Neurology. 2016;275:367–80. doi:10.1016/j.expneurol.2015.05.024. Cited in: PMID: 26112314.
   PubMed Web of Science ®Google Scholar
• Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2018;23(2):335–43. doi:10.1038/mp.2016.167. Cited in: PMID: 2775207.
   PubMed Web of Science ®Google Scholar
• Lehrer S, Rheinstein PH. Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce suicidal ideation and depression. Discov Med. 2019 Oct;28(154):205–12. Cited in: PMID: 31928628.
   PubMed Web of Science ®Google Scholar
• Kohler O, Krogh J, Mors O, Benros ME. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. CurrNeuropharmacol. 2016;14(7):732–42. doi:10.2174/1570159x14666151208113700. Cited in: PMID: 27640518.
   Web of Science ®Google Scholar
• Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, et al. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry. 2012 Oct;169(10):1065–72. doi:10.1176/appi.ajp.2012.11091325. Cited in: PMID: 23032386.
   PubMed Web of Science ®Google Scholar
• Uzzan S, Azab AN. Anti-TNF-α compounds as a treatment for depression. Molecules. 2021 Apr 19;26(8):2368. doi:10.3390/molecules26082368. Cited in: PMID: 33921721.
   PubMed Web of Science ®Google Scholar
• Brymer KJ, Romay-Tallon R, Allen J, Caruncho HJ, Kalynchuk LE. Exploring the potential antidepressant mechanisms of TNFα antagonists. Front Neurosci. 2019 Feb 11;13:98. doi:10.3389/fnins.2019.00098. Cited in: PMID: 30804748.
   PubMed Web of Science ®Google Scholar
• De Giorgi R, Rizzo Pesci N, Quinton A, De Crescenzo F, Cowen PJ, Harmer CJ. Statins in depression: an evidence-based overview of mechanisms and clinical studies. Front Psychiatry. 2021 Jul 27;12:702617. doi:10.3389/fpsyt.2021.702617. Cited in: PMID: 34385939.
   PubMed Web of Science ®Google Scholar
• Colle R, de Larminat D, Rotenberg S, Hozer F, Hardy P, Verstuyft C, Fève B, Corruble E. PPAR-γ agonists for the treatment of major depression: a review. Pharmacopsychiatry. 2017 Mar;50(2):49–55. doi:10.1055/s-0042-120120. Epub 2016 Dec 15. Cited in: PMID: 27978584.
   PubMed Web of Science ®Google Scholar
• Tsai PY, Chen YC, Wang JY, Chung KH, Lai CH. Effect of repetitive transcranial magnetic stimulation on depression and cognition in individuals with traumatic brain injury: a systematic review and meta-analysis. Sci Rep. 2021 Aug 20;11(1):16940. doi:10.1038/s41598-021-95838-2. Cited in: PMID: 34417481.
   PubMed Web of Science ®Google Scholar
• Siddiqi SH, Trapp NT, Hacker CD, Laumann TO, Kandala S, Hong X, Trillo L, Shahim P, Leuthardt EC, Carter AR, et al. Repetitive transcranial magnetic stimulation with resting-state network targeting for treatment-resistant depression in traumatic brain injury: a randomized, controlled, double-blinded pilot study. J Neurotrauma. 2019 Apr 15;36(8):1361–74. doi:10.1089/neu.2018.5889. Epub 2019 Jan 7. Cited in: PMID: 30381997.
   PubMed Web of Science ®Google Scholar
• Reti IM, Schwarz N, Bower A, Tibbs M, Rao V. Transcranial magnetic stimulation: a potential new treatment for depression associated with traumatic brain injury. Brain Inj. 2015;29(7–8):789–97. doi:10.3109/02699052.2015.1009168. Epub 2015 May 7. Cited in: PMID: 25950260.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. 2013. doi:10.1176/appi.books.9780890425596.
   Google Scholar